Organization
- EUCAST statutes
- Steering Committee
- General Committee
- Subcommittees
- National AST Committees (NAC)
- Development Laboratories
- Network Laboratories
Public consultations
EUCAST News
Definitions of S, I and R
Clinical breakpoints and dosing
- About "Clinical breakpoints".
- Rationale documents
- Splitting MIC wild type distributions
- When there are no breakpoints?
- Breakpoints in brackets
- EUCAST setting breakpoints.
Rapid AST in blood cultures
- Calibration files
- RAST from EUCAST in publications
- Methods
- QC
- Breakpoints for short incubation
- Screening for resistance mechanisms with RAST
- FAQ on RAST
Expert rules and expected phenotypes
- Expected phenotypes
Resistance mechanisms
Guidance documents
SOP
MIC and zone distributions and ECOFFs
- Information o distributions
- New and revised ECOFFs
AST of bacteria
- IVDR
- Media preparation
- MIC determination
- Disk diffusion methodology
- Disk diffusion implementation
- Quality Control
- Strains with defined susceptibility
  - S. pneumoniae
  - P. aeruginosa
- Calibration and validation
- Warnings!
- MIC testing services from EUCAST
- Previous versions of documents
AST of mycobacteria
- AMST organisation
- Clinical breakpoints for antimycobacterial agents
- MIC & ECOFFs
- Methods in Mycobacteria
- FAQ Mycobacteria
- RDs
- Scientific publications
- Meetings & Minutes
AST of fungi
- Breakpoints for antifungals
- MIC distributions and ECOFFs
- Methods in antifungal susceptibility testing
- QC AFST Tables
- Rationale documents for antifungals
- Documents for discussion in AFST
- Publications in journals
- Meetings, Minutes and Reports
- Previous versions of documents
AST of phages
- Subcommittee members
AST of veterinary pathogens
- VetCAST rationale documents
- VetCAST meetings
Frequently Asked Questions (FAQ)
Meetings
- EUCAST meetings
Rationale documents and publications
- Rationale Documents
- Consultations
- Publications in journals
- Technical notes
- Posters
- External documents
- Reports
Presentations and statistics
Videos and online seminars
- Online seminars
- Seminar links
- English
- Chinese
Warnings!
Translations
- EUCAST in Serbian
Information for industry
Links and Contacts
- EUCAST Contact form

AST of fungi

Clinical breakpoints for fungi (Candida and Aspergillus species)

Current tables

Clinical breakpoints for fungi v. 11.0 (PDF file for printing) - valid from 2 December, 2024
Clinical breakpoints for fungi v. 11.0 (Excel file for screen) - valid from 2 December, 2024
What to do when there are no breakpoints - guidance for rare yeasts - first published on 16 April 2024, errata published 30 Sep, 2024: “dashes (“-“) are replaced by R, C. dubliniensis has been deleted as BPs have been set, and the species (dermatis) specified in table 2.”
Overview of antifungal ECOFFs and clinical breakpoints for yeasts and moulds - valid from 2 December 2024.

Archived tables

Clinical breakpoints for fungi v. 10.0 (PDF file for printing) - valid from 4 February 2020; links updated Sept 2020.
Clinical breakpoints for fungi v. 10.0 (Excel file for screen) - valid from 4 February 2020;links updated Sept 2020.
Clinical breakpoints for fungi v 9.0 (pdf-file for printing) - valid from 12 February, 2018
Clinical breakpoints for fungi v 9.0 (Excel file for screen) - valid from 12 February, 2018
Overview of antifungal ECOFFs and clinical breakpoints for yeasts and moulds - valid from 14 August, 2023; Previous version valid from 18 January 2022; Previous version valid from 24 September, 2020.